Osaic Holdings’s Lifecore Biomedical LFCR Stock Holding History

Osaic Holdings’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05K	Sell	200 -143	-42%	-$720	﹤0.01%	7469
2026 Q1	$1.27K	Buy	+343	New	+$2.37K	﹤0.01%	7186
2025 Q4	–	Sell	-53	Closed	-$390	–	8021
2025 Q3	$390	Buy	+53	New	+$401	﹤0.01%	7586
2024 Q1	–	Sell	-549	Closed	-$3.4K	–	7310
2023 Q4	$3.4K	Buy	549 +415	+310%	+$2.88K	﹤0.01%	6327
2023 Q3	$1.01K	Hold	134	–	–	﹤0.01%	6820
2023 Q2	$1.3K	Sell	134 -275	-67%	-$1.68K	﹤0.01%	6803
2023 Q1	$1.54K	Buy	+409	New	+$2.28K	﹤0.01%	6814
2021 Q4	–	Sell	-334	Closed	-$3K	–	7487
2021 Q3	$3K	Buy	+334	New	+$3.63K	﹤0.01%	6744

Other funds holding LFCR

Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Osaic Holdings's LFCR Position: Q2 2026 in Review

Osaic Holdings reduced its Lifecore Biomedical (LFCR) stake by 42% in Q2 2026, selling an estimated $720 and leaving 200 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #7469.

Osaic Holdings first reported a position in LFCR in Q3 2021 and has held it in 8 quarters since. The position peaked at $3.4K in Q4 2023. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

Osaic Holdings held 200 shares of Lifecore Biomedical worth $1.05K as of Q2 2026.
Osaic Holdings sold 143 Lifecore Biomedical shares in Q2 2026, an estimated $720.
Lifecore Biomedical made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7469 holding.
Osaic Holdings first reported a position in Lifecore Biomedical in Q3 2021 and has held it in 8 quarters since.
Osaic Holdings's Lifecore Biomedical position peaked at $3.4K in Q4 2023.
98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.